Numerous studies have revealed that MIR31HG is positively related to clinicopathological features, including tumour size, clinical stage, TNM stage, advanced T category, lymph node metastasis, distant metastasis, overall survival, and progression-free survival (Table1). The gene discussed is MIR31HG; the disease is neoplasm.